World-renowned expertise. Singularly focused.
Since Memorial Sloan Kettering Cancer Center (MSK) was established in New York City in 1884, our specialists have cared for adult and pediatric patients across the U.S. with uncompromising empathy and cutting-edge medicine. Our doctors treat more cancer patients in a single year than most do in a lifetime, resulting in some of the best — and most inspiring — health outcomes in the industry.
For more than 34 years, U.S. News & World Report has honored MSK as one of the top 2 cancer hospitals in the nation. We’re proud of the “best hospital” distinction, but we’re even more proud of our exceptionally dedicated and compassionate staff.
About MSK Direct
MSK Direct was introduced in 2016 to make world-class cancer care accessible for employees and their loved ones, regardless of their job title or where they live. MSK Direct seeks to mitigate the traditional barriers to accessing high quality cancer care by providing individuals with the appropriate subspecialized expertise in the care setting that is best for them.
The program is supported at the highest levels of Memorial Sloan Kettering Cancer Center with full institutional backing of our executive leadership, board of directors, and subspecialized medical faculty.
We work collaboratively with employers, unions, benefits consultants, health plans, and third-party administrators to solve some of the toughest challenges to support employees and members across the nation who have or are concerned about cancer.
Screening services
We are experts in early cancer screening, prevention, and detection.
Leading physicians
MSK employs 1,417 of the world’s leading physicians.
Common and rare cancers
We specialize in every type and subtype of cancer.
Leadership
Sergio A. Giralt, MD
Chief Medical Officer, MSK Direct; Deputy Division Head, Division of Hematologic Malignancies; Melvin Berlin Family Chair in Multiple Myeloma
Dr. Giralt serves as the Chief Medical Officer for MSK Direct. Joining MSK in 2010, he led the Adult Bone Marrow Transplant Service as its Chief until February 2020. As a board-certified hematologist-oncologist, Dr. Giralt’s clinical activity and research focus on stem cell transplantation for patients with blood disorders.
Dr. Giralt’s clinical leadership and oversight for MSK Direct enhances our efforts to provide more than 7 million members with equitable and personalized access to the lifesaving discoveries and subspecialized expertise of MSK.
Emily Kauff
Executive Director, MSK Direct; Vice President New Markets
Emily Kauff has over twenty years of partnership and product development experience in healthcare and financial services.
As Executive Director, Emily develops partnerships and digital solutions to help employers, unions, and health service companies across the United States and internationally make informed decisions about their member’s cancer care, whether accessed virtually or at MSK. Through MSK Direct, she strives to make access to the care and the expertise from MSK simple and easy for patients, no matter where they live.
Prior to joining MSK, Emily held a number of leadership positions at American Express. While at American Express, Emily launched The Centurion Lounge, a global benefit for Cardmembers, and led servicing and operations for American Express’ prepaid products.
Kelly Turner
Vice President, Patient Access Program
Kelly Turner joined MSK in 2010 as a Care Coordinator, a role in which she discovered her passion for operations and supporting patients throughout their cancer journey. Since 2017, Kelly has led Patient Access Programs, which schedules over 75,000 patient appointments annually, managing over 1,200 phone calls daily from prospective patients and their loved ones.
Under Kelly’s leadership, Patient Access has achieved a 4.76 star rating and a Net Promoter Score of 86. She sits on the Executive Committee of the Patient Access Collaborative, which is the forum for the nation’s largest and most prestigious health system to advance initiatives that vastly improve patient access.
Kelly is passionate about the patient and clinician experience. She is constantly striving to make a measurable impact that reduces the overall burden for patients and utilizes data to highlight our most vulnerable populations.
Greg Green
Director of Business Development, MSK Direct
Greg Green leads the MSK Direct Business Development team and oversees new strategic partnerships with employers, labor unions, health plans, digital health companies, and other channel partners. Greg is dedicated to bringing value to partners by reducing the burden of cancer for individuals and large, diverse groups alike. Inspired by both a desire for change in the healthcare industry and seeing firsthand the transformative impact that MSK Direct has had for individuals across the country, Greg’s goal is to extend MSK’s leading subspecialized expertise to individuals and their families, wherever they are, in their time of need.
Prior to joining MSK, Greg worked for a decade in hospital consulting, partnering with hospitals and healthcare system across the nation on revenue cycle improvement, technology development, chronic disease management programs, and Center of Excellence initiatives.
Cole Manship
Director of Product, MSK Direct
Cole Manship is Director of Product for MSK Direct, overseeing MSK Direct’s product strategy in collaboration with teams across MSK to develop new and innovative capabilities. As a cancer survivor and digital health leader, Cole has a strong passion for using digital solutions to expand access to leading oncology expertise and holistic support for individuals impacted by cancer.
Cole is an inventor on several patents and frequent speaker on the topics of product strategy and digital health.
Steve Brightwell
Director of Partnerships, MSK Direct
Steve Brightwell leads the MSK Direct Partner Engagement team, managing existing relationships with commercial employers and unions across the United States. Steve’s commitment to building strong, trusting, consultative relationships with our customers is his top priority.
Prior to joining MSK, Steve held various contributor and leadership positions in the healthcare sector including Kaiser Permanente, William Mercer Consulting, Alere Health, and SPH Analytics.